Tier 3 · Filer Universe

Mereo BioPharma Group plc

MREO · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$0.31
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001719714
Liquidity rank
#5202
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$500,000.002025-12-310001193125-26-115226
Annual diluted EPS-0.052025-12-310001193125-26-115226
Quarterly revenue$0.002025-09-300001193125-25-274272
Quarterly diluted EPS-0.012026-03-310001193125-26-218232

SEC EDGAR Frames batch generated 2026-07-16T23:27:27.073Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerTMO · Tier 1 peerDHR · Tier 1 peerAMGN · Tier 1 peer

Provenance